2020-11-16T20:11:49-05:00 2019-12-31 042666565 John M Monticone CPA 5 High Street Suite 207 Medford MA 02155 990 2019-01-01 043333682 BEDFORD RESEARCH FOUNDATION BEDF 124 SOUTH ROAD Bedford MA 017302344 Ann Kiessling PhD President 6176235670 2020-11-15 true John M Monticone CPA P01257043 7813950024 2020-11-16 X 2019 2022-09-23 18:48:47Z X Ann Kiessling PhD 886932 false X WWW.BEDFORDRESEARCH.ORG X 1996 MA Stem cell research, prostate disease research and HIV Research. 15 14 8 14 0 0 53178 75931 942893 783152 21374 27849 0 1017445 886932 0 0 375397 407421 0 14545 402487 380342 777884 787763 239561 99169 940769 1118415 57360 39435 883409 1078980 Stem cell research, prostate disease research and HIV Research. false false 697167 783152 Special program of Assisted Reproduction takes advantage of Assited Reproduction Technology procedures to assist couples achieve a pregnancy who would otherwise risk transmitting the fathers infection to the mother and the child through intercourse. During this process, researches gathered information to prevent the transmission of sexually transmitted deseases. HIV Research. 697167 true true false false false false false false false true true false false false false true true false false false false false false false false false false false false false false false false false false false false true false false false false false false false false false false true 3 0 true 8 true false false false false false false false false false false false false false false false false X 15 14 false false false false false false false true false false false true true true true true true true false false MA X X Ann Kiessling PhD 6176235670 124 SOUTH ROAD Bedford MA 017302344 Ann Kiessling PhD President 40.00 0.00 X X 78865 0 0 Alan Geismer Esq Chairman 0.30 0.00 X X 0 0 0 John D Lee MEd Secretary 0.30 0.00 X 0 0 0 Larry LaFranchi MBA Treasurer 1.00 0.00 X X 0 0 0 Anil Purohit PhD Director 0.30 0.00 X 0 0 0 Ellen Sheehy MBA Director 0.30 0.00 X 0 0 0 Margaret Wray BSN Director 0.30 0.00 X 0 0 0 Robert A Kaufmann MD Director 0.30 0.00 X 0 0 0 Scott C Anderson Director 0.30 0.00 X 0 0 0 Susan L Moss JD PhD Director 0.30 0.00 X 0 0 0 Yael Schwartz PhD Director 0.30 0.00 X 0 0 0 Lawrence R Jones MS Director 0.30 0.00 X 0 0 0 Sean Kealy Esq Director 0.30 0.00 X 0 0 0 Alan Mayer Director 0.30 0.00 X 0 0 0 Jose Cibelli DVM PhD Director 0.30 0.00 X 0 0 0 78865 0 0 0 false false false 75931 75931 Assisted reproduction 621500 783152 783152 783152 27849 27849 886932 783152 0 27849 78866 70979 7887 285082 246337 31095 7650 11119 9694 1191 234 2608 2274 279 55 29746 25935 3186 625 4500 4500 12931 12056 875 6080 6080 13610 3064 10546 73687 65581 5895 2211 8347 7011 668 668 32849 32849 12481 12481 6654 5801 713 140 Telephone 11316 8487 2263 566 Postages 4136 1380 1378 1378 Donor and Lab supplies 171878 171878 Repairs and maintenance 20373 15280 4075 1018 1500 1500 787763 697167 76051 14545 171888 124866 111071 191620 10310 9785 4000 4000 237923 176280 13401 61643 618099 714501 12000 12000 940769 1118415 39160 24835 18200 14600 57360 39435 X 878409 1050480 5000 28500 883409 1078980 940769 1118415 99169 96402 0 X X false true X true false X 51746 45564 59285 53178 75931 285704 642511 568409 714956 961093 783152 3670121 694257 613973 774241 1014271 859083 3955825 10000 40500 43720 30000 124220 10000 40500 43720 30000 124220 3831605 9664 8318 10967 21374 27849 78172 9664 8318 10967 21374 27849 78172 703921 622291 785208 1035645 886932 4033997 0.94980 0.95480 0.02000 0.02000 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 5000 25000 1500 28500 5500 5000 5500 5000 15500 10000 5500 13600 13600 4500 5000 9500 1.00000 false false 29529 29529 208394 146751 61643 61643 Security Deposit 12000 12000 X 983334 96402 96402 886932 886932 787763 787763 787763 Endowment funds intended uses (Part V, line 4) Temporarily Restricted Funds are intended for the following purposes:Stem Cell Research $3,500MINC Benchtop Incubator project 25,000 Total $28,500 Footnote for uncertain tax position under FIN 48 (Part X) The Organization currently evaluates all tax positions, and makes a determination regarding the likelihood of those positions being upheld under review. The primary tax positions made by the Organization are the existence of unrelated business income tax and the Organizations status as a Tax-exempt Organization under Section 501(c)(3) of the Internal Revenue Code. For the years presented, the Organization has not recognized any tax benefits or loss contingencies for uncertain tax positions based on this evaluation. All tax periods prior to fiscal year ended December 31, 2016 are no longer subject to examination by tax authorities. Dr Ann Kiessling PresidentExecDirector 58236 See supplemental information false Dr Ann Kiessling PresidentExec Director 78865 Compensation as Executive Director false Ryan Kiessling Presidents son 93000 Compensation as Operations Director false Supplemental Information for Schedule L Part IV - Business Transactions Involving Interested Persons:During the year 2016, the Organization has signed a five year lease for Office space with a for profit entity, which is owned by the President and board member of the Organization. The lease calls for current monthly base rent of $6,744. For the year 2019, the Organization paid $58,236 in rent to this related party. Committee meeting documentation Part VI line 8b No committee has the authority to act on behalf of the governing body. Form 990 governing body review Part VI line 11 Two weeks before filing the 990 form, a copy is given to each board of directors for review and discussion. Conflict of interest policy compliance Part VI line 12c The organization requires each new key employee, officer or director to review a copy of the Policy on Conflict of Interest and Disclosure of Certain Interests and to acknowledge in writing that he or she has done so. Additionally, each key employee, officer or director, annually complete a disclosure form identifying any relationships, positions or circumstances in which the employee is involved that he or she believes could contribute to a conflict of interest arising. CEO executive director top management comp Part VI line 15a The board of directors establishes the compensation for the Executive Director that are within the range or organizations similar in size and scope of Bedford Research Foundation. Governing documents etc available to public Part VI line 19 Copy of the financial statements and current year changes in the governing documents, conflict of interest policy are attached to the PC Form which is filed in the Secretary of State and available for public inspection. Also, copy of these documents are available at the organizations office at 124 South Road, Bedford, MA 01730, for public inspection upon request. Audited by an independent accountant Part XII line 2b The Organizations President and Treasurer have the responsibility to oversight the Review and the selection of the independent accountant. Explanation of other changes in net assets or fund balances Part XI line 9 Market Value appreciation of investments